课题基金 / 基金详情

Discovery of agents that induce exosomes with adjuvant activity

Discovery of agents that induce exosomes with adjuvant activity
发现具有佐剂活性的外泌体诱导剂
批准号：
10027065
负责人：
DENNIS CARSON
金额：
$212.77万
依托单位：
UNIVERSITY OF CALIFORNIA, SAN DIEGO
依托单位国家：
美国
项目类别：
财政年份：
2019
资助国家：
美国
项目状态：
已结题
起止时间：
2019-09-30 至 2020-09-29
来源：
https://reporter.nih.gov/project-details/10027065
关键词：
Adaptive Immune SystemAdjuvantAnimal ModelAntigensAwardB-LymphocytesCellsContractorFDA approvedHumanImmunologic MemoryInnate Immune SystemLibrariesPreventive vaccineResearchT-LymphocyteTestingVaccinesexosomehuman diseaseinfluenza virus vaccinenovelpathogenresponsesmall moleculetherapeutic vaccinevaccine efficacy

项目摘要

项目成果

DENNIS CARSON的其他基金

相似基金

相关文献

中文摘要
翻译
承包商将确定可用于增强人类疫苗效力的新佐剂候选药物。在该奖项下进行的研究将有助于开发新的佐剂线索，这些线索要么：(A)利用天然免疫系统的天然能力，启动和维持有效的T和B细胞反应，并诱导长期免疫记忆；要么(B)直接作用于适应性免疫系统的细胞，以增强它们对病原体衍生抗原的反应。 研究包括在相关动物模型中测试试验性或FDA批准的预防性或治疗性疫苗的候选佐剂，以确定疫苗对一种或多种与人类疾病相关的病原体的潜在效力。
英文摘要
The contractor will identify novel adjuvant candidates that can be used to augment the efficacy of human vaccines. Research performed under this award will contribute to the pipeline of new adjuvant leads that either: (a) exploit the natural capacity of the innate immune system to initiate and sustain effective T and B cell responses and to induce long term immune memory, or (b) act directly on cells of the adaptive immune system to enhance their response to pathogen-derived antigens. Studies include testing of adjuvant candidates with experimental or FDA approved preventative or therapeutic vaccines in relevant animal models to determine the potential efficacy of the vaccine against one or more pathogens relevant to human disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Tetrahydrothieno[2,3-c]pyridines as Vaccine Co-adjuvants
Discovery of agents that induce exosomes with adjuvant activity
Discovery of agents that induce exosomes with adjuvant activity
Discovery of agents that induce exosomes with adjuvant activity
海外基金